Friday, July 10, 2026

Drug profile · INN

fluoroestradiol f-18

fluoroestradiol f-18 (CERIANNA) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — fluoroestradiol f-18
US status
approved
Class
Route
INTRAVENOUS
Patents
0
Programs
0
Data quality
0.84

Quick answer

fluoroestradiol f-18 (CERIANNA) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.

Key facts

INN fluoroestradiol f-18
Brand CERIANNA
Mechanism Diagnostic agent
Route INTRAVENOUS
Formulation SOLUTION

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is fluoroestradiol f-18?

fluoroestradiol f-18 (CERIANNA) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.

What is the brand name for fluoroestradiol f-18?

CERIANNA is a marketed brand name for fluoroestradiol f-18. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of fluoroestradiol f-18?

fluoroestradiol f-18 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.